Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-25-002410)

Filing Details

Accession Number:: 0001493152-25-002410
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-15 17:00:16
Reporting Period:: 2025-01-13

Accepted Time:: 2025-01-15 17:00:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1167028	W Patrick Smith	C/O Oncocyte Corporation 15 Cushing Irvine CA 92618		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2025-01-13	5,669	$2.08	1,779,572	No	4	P	Indirect	See footnote
Common Stock, No Par Value	Acquisiton	2025-01-14	100	$2.08	1,779,672	No	4	P	Indirect	See footnote
Common Stock, No Par Value	Acquisiton	2025-01-14	10,286	$2.15	1,789,958	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.